Clinical Trial Update: 40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(P05786) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety of adding asenapine to lithium or valproate in bipolar disorder has completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Asenapine (asenapine)
• Lithium (Lithium carbonate)
• Valproate (valproate)

Snippet

Sponsor: Organon and Co | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED | Results posted: 2010-04-16